Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxart Inc VXRT

Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its development programs include pill vaccines designed to protect against norovirus (cause for acute gastroenteritis), coronavirus, including SARS-CoV-2 (COVID-19)), and influenza. In addition, it has generated preclinical data for its therapeutic vaccine candidate targeting cervical cancer and dysplasia caused by human papillomavirus. The Company's platform technology employs a vector-based approach and consists of various components, such as a vector (adenovirus type 5 (Ad5); an antigen (Ad5 DNA); an adjuvant (Toll-like receptor 3 (TLR3)), and its proprietary enteric-coated tablet.


NDAQ:VXRT - Post by User

<< Previous
Bullboard Posts
Next >>
Post by thevisionary2kon Feb 11, 2021 9:14am
153 Views
Post# 32535908

VXRT - BlackRock and Vanguard

VXRT - BlackRock and Vanguard

BlackRock, the world's largest asset manager, with $8.67 trillion in assets under management as of January 2021, increased its VXRT position to 4.9 million shares as of 12/31/20, a jump of 645% versus 9/30/20.

 

The Vanguard Group, Inc., an American registered investment advisor with about $6.2 trillion in global assets under management as of January 31, 2020, holds 5 million shares of VXRT.

 

BlackRock and Vanguard are two of the world’s leading asset management and investment advisory firms, and very bullish on VXRT.

 

https://www.nasdaq.com/market-activity/stocks/vxrt/institutional-holdings

<< Previous
Bullboard Posts
Next >>